These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38270775)

  • 41. Correlation between peripheral blood CD4+CD25high CD127low regulatory T cell and clinical characteristics of patients with non-Hodgkin's lymphoma.
    Lin H; Sun XF; Zhen ZJ; Xia Y; Ling JY; Huang HQ; Xia ZJ; Lin TY
    Ai Zheng; 2009 Nov; 28(11):1186-92. PubMed ID: 19895740
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Non-Hodgkin Lymphoma - Nodal and Extranodal: 20-Year Comparative Mortality, Survival & Biologic Behavior Analysis by Age, Sex, Race, Stage, Cell Morphology/Histology, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 384,651 Total NHL Cases Including 261,144 Nodal and 123,507 Extranodal Cases for Diagnosis Years 1975-2016: (SEER*Stat 8.3.6).
    Milano AF
    J Insur Med; 2023 Jul; 50(1):1-35. PubMed ID: 37725503
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical significance of suppressor of cytokines signalling-3 mRNA expression from patients with non-Hodgkin lymphoma under chemotherapy.
    Attia FM; Hassan AM; El-Maraghy NN; Ibrahium GH
    Cancer Biomark; 2011-2012; 11(1):41-7. PubMed ID: 22820139
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Decreased dickkopf-1 levels in chronic lymphocytic leukemia and increased osteopontin levels in non-Hodgkin's lymphoma at initial diagnosis: Could they be playing roles in pathogenesis?
    Pamuk GE; Uyanik MS; Pamuk ON; Maden M; Tapan U
    Hematology; 2015 Jun; 20(5):267-71. PubMed ID: 25271869
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Expression of lactate dehydrogenase-5 in non-Hodgkin lymphoma and its clinical significance].
    Dong F; Sui A; Jing H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 41(12):1312-1316. PubMed ID: 28070044
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Plasma cell-free DNA is a prognostic biomarker for survival in patients with aggressive non-Hodgkin lymphomas.
    Hur JY; Kim YJ; Yoon SE; Son DS; Park WY; Kim SJ; Park D; Kim WS
    Ann Hematol; 2020 Jun; 99(6):1293-1302. PubMed ID: 32296914
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Analysis of clinical characteristics, diagnosis, treatment and prognosis of 46 patients with primary gastrointestinal non-Hodgkin lymphoma.
    Ding D; Pei W; Chen W; Zuo Y; Ren S
    Mol Clin Oncol; 2014 Mar; 2(2):259-264. PubMed ID: 24649343
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum CA 125 is of clinical value in the staging and follow-up of patients with non-Hodgkin's lymphoma: correlation with tumor parameters and disease activity.
    Lazzarino M; Orlandi E; Klersy C; Astori C; Brusamolino E; Corso A; Bellio L; Gargantini L; Morra E; Bernasconi C
    Cancer; 1998 Feb; 82(3):576-82. PubMed ID: 9452277
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The biological markers of non-Hodgkin's lymphomas: their role in diagnosis, prognostic assessment and therapeutic strategy.
    Morra E
    Int J Biol Markers; 1999; 14(3):149-53. PubMed ID: 10569136
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Incidence of extranodal non-Hodgkin lymphomas among whites, blacks, and Asians/Pacific Islanders in the United States: anatomic site and histology differences.
    Wu XC; Andrews P; Chen VW; Groves FD
    Cancer Epidemiol; 2009 Nov; 33(5):337-46. PubMed ID: 19853554
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Ki-67 proliferative index in non-Hodgkin's lymphoma and its clinical significance].
    Li J; Hu R; Liao AJ; Shi HY; Yan W; Liu ZG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):935-9. PubMed ID: 21867618
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Standardized uptake value for (18)F-fluorodeoxyglucose is correlated with a high International Prognostic Index and the presence of extranodal involvement in patients with diffuse large B-cell lymphoma.
    Akkas BE; Vural GU
    Rev Esp Med Nucl Imagen Mol; 2014; 33(3):148-52. PubMed ID: 24094371
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epstein-Barr virus genome in non-Hodgkin's lymphomas occurring in immunocompetent patients: highest prevalence in nonlymphoblastic T-cell lymphoma and correlation with a poor prognosis. Danish Lymphoma Study Group, LYFO.
    d'Amore F; Johansen P; Houmand A; Weisenburger DD; Mortensen LS
    Blood; 1996 Feb; 87(3):1045-55. PubMed ID: 8562929
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster Group Report.
    Salzburg J; Burkhardt B; Zimmermann M; Wachowski O; Woessmann W; Oschlies I; Klapper W; Wacker HH; Ludwig WD; Niggli F; Mann G; Gadner H; Riehm H; Schrappe M; Reiter A
    J Clin Oncol; 2007 Sep; 25(25):3915-22. PubMed ID: 17761975
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characteristics and outcomes of children, adolescents and young adults with relapsed/refractory non-hodgkin lymphoma undergoing autologous stem cell transplant.
    Pasvolsky O; Bassett RL; Ghanem S; Cuglievan B; Tewari P; Hosing C; Srour S; Ramdial J; Mahadeo KM; Khazal S; Petropoulos D; Popat U; Qazilbash M; Kebriaei P; Champlin R; Shpall EJ; Nieto Y
    BMC Cancer; 2023 Dec; 23(1):1258. PubMed ID: 38124057
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic Value of miRNA-155 Expression in B-Cell Non-Hodgkin Lymphoma.
    Bedewy AML; Elmaghraby SM; Shehata AA; Kandil NS
    Turk J Haematol; 2017 Aug; 34(3):207-212. PubMed ID: 28148469
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Plasma interleukin-6 and interleukin-10 levels in different subtypes of lymphoma and their clinical significance].
    Wang X; Zhao HR; Gu X; Liu P; Bikmituofu H
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Aug; 31(8):1360-4. PubMed ID: 21868324
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Does beta-2 microglobulin measurement play role in diagnostics of childhood malignancies?].
    Bień E; Balcerska A; Ciesielski D
    Wiad Lek; 2004; 57(1-2):8-11. PubMed ID: 15181741
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical features and prognosis of double primary malignant neoplasms in patients with non-hodgkin lymphoma.
    Zhan Z; Guo W; Li J; Wan X; Guo J; Bai O
    Discov Oncol; 2023 May; 14(1):54. PubMed ID: 37133771
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum beta 2-microglobulin in malignant lymphoproliferative disorders.
    Melillo L; Musto P; Tomasi P; Cascavilla N; Bodenizza C; Ladogana S; Carotenuto M
    Tumori; 1988 Apr; 74(2):129-35. PubMed ID: 3285553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.